Virtual Patient: Adult Male with Reaction to Flying Hymenoptera Sting
This patient simulation involves an adult male who had a severe reaction to a flying hymenoptera sting. Based on the clinical history and test results, the learner will choose the best way to treat the patient with immunotherapy. The learner will answer specific questions that explain the immunotherapy treatment, including risks, intervals, duration, and possibility of relapse to the patient. The learner will receive feedback for each decision that is made, and numerous references that discuss best practices for using allergen immunotherapy will be provided.
Making IT Count is funded through an educational grant from Merck & Co., Inc.
- Allied Health providers
Upon completion of this activity, participants should be able to:
- Make appropriate treatment decisions for an adult male patient who suffered a reaction after a flying hymenoptera sting
- Answer detailed questions about the immunotherapy treatment administered to the patient
- Handle subsequent reactions with medications and adjustments to the treatment
Christopher W. Calabria, MD FAAAAI
Dilley Allergy and Asthma, San Antonio, TX
Relevant relationships: None
Mike Tankersley, MD FAAAAI
University of Tennessee Health Science Center, Memphis, TN
Relevant relationships: None
AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:
- Employment: Name of employer and job title.
- Financial interests: All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
- Research interests: All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
- Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
- Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
- Gifts: All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
- Other interests: All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.
The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE Designation Statement
The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 0.25 Contact Hours.
Credit Claiming Period
Credit claiming for this activity will expire at 11:59 pm on July 3, 2020. Requests to claim credit on or after July 3, 2020 will be denied.
Medium and Method of Physician Participation
Follow these steps to complete the activity:
- Register for the activity.
- Review the CME and Disclosure information.
- Complete all required components.
- Complete the Commmitment to Change form.
- Complete the activity evaluation.
- Claim your credits.
- Print or save your certificate.
To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at email@example.com.
Original release date: March 3, 2016. Reviewed by Christopher Calabria, MD FAAAAI on April 20, 2018. Valid for credit through July 3, 2020.
Activity-related questions should be directed to firstname.lastname@example.org
- 0.25 AttendanceAttendance credit.
- 0.25 CECE credit.
- 0.25 CMECME credit.